Combined use of Feitai capsule and antituberculosis agents in initial treatment of pulmonary tuberculosis

WANG Pu; et al

doi:10.13406/j.cnki.cyxb.2005.06.030

您当前的位置：

首页 >

文章列表页 >

Combined use of Feitai capsule and antituberculosis agents in initial treatment of pulmonary tuberculosis

更新时间：2024-01-17

- Combined use of Feitai capsule and antituberculosis agents in initial treatment of pulmonary tuberculosis
- Journal of Chongqing Medical University Issue 6, Pages: 881-883(2005)
- 作者机构：
  
  1. 重庆医科大学附属第一医院呼吸内科
  2. 重庆医科大学附属第一医院呼吸内科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2005.06.030
  CLC： R259
- Published：2005，
扫描看全文
[1]王璞,罗永艾,黄习臣,齐云.肺泰胶囊辅助治疗初治肺结核的临床研究[J].重庆医科大学学报,2005(06):881-883.

WANG Pu, et al. Combined use of Feitai capsule and antituberculosis agents in initial treatment of pulmonary tuberculosis. [J]. Journal of Chongqing Medical University (6):881-883(2005)
[1]王璞,罗永艾,黄习臣,齐云.肺泰胶囊辅助治疗初治肺结核的临床研究[J].重庆医科大学学报,2005(06):881-883. DOI： 10.13406/j.cnki.cyxb.2005.06.030.

WANG Pu, et al. Combined use of Feitai capsule and antituberculosis agents in initial treatment of pulmonary tuberculosis. [J]. Journal of Chongqing Medical University (6):881-883(2005) DOI： 10.13406/j.cnki.cyxb.2005.06.030.

摘要

目的:评价肺泰胶囊联合抗结核西药治疗初治肺结核的临床疗效和安全性。方法:53例初治肺结核患行

随机分为试验组和对照组

38例试验组病例服用肺泰胶囊+2HL2Z／4HL2治疗6月

15例对照组病例服用安慰剂+2HL2Z／4HL2治疗6月

观察治疗2月末和6月末痰结核菌阴转X线胸片上病灶和空洞变化情况。结果:治疗2月未痰结核菌阴转率试验组为93．8％

对照组为42．9％

病灶显吸率试验组为50％

对照组为13．3％;治疗6月末两组痰菌阴转率均为100％

病灶全吸率试验组为42．1％

对照组为13．3％

空洞闭合率试验组为78．6％

对照组为28．6％。试验组均优于对照组

差异有显著性意义（P<0．05）。肺泰胶囊未见不良反应。结论:肺泰胶囊与抗结核西药联合治疗初治肺结核患者

能加速痰结核菌阴转和病灶吸收

提高空洞闭合率

是一种有效而安全的抗结核中药制剂。

Abstract

Objective To evaluate the clinical efficacy and safety of Feitai capsule and antituberculosis agents in initially treatment of pulmonary tuberculosis patients. Methods:38 patients were administrated with Feitai capsule and antituberculosis agents for6 months. 15 patients were treated with placebo and anti-tuberculosis angents for 6 months. The changes were observed at 2 and 6 months after treatment

which were changes of sputum smear from positive to negative

lesions and cavities on radiography. Adverse drug reactions were observed during the whole treatment course. Results:The duration of change in sputum tuberculosis smear from positive to negative was short and the absorption rates of lesions and cavities on radiography were greater in the group of Feitai capsule than those of the control group. No evident adverse drug reaction was found. Conclusion: Feitai capsule is a kind of traditional Chinese medicine that accelerates the improvement of pulmonary tuberculosis patients at initial treatment stage as antituberculosis agent. It is effective and safe.

关键词

肺结核治疗肺泰胶囊

Keywords

pulmonary tuberculosistreatmentFeitai capsule

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Treatment of renal tuberculosis complicated with active pulmonary tuberculosis

Research progress in the diagnosis and treatment of non-eosinophilic asthma

Clinical features and treatment outcome of scrotal abscess: an analysis of 24 cases

Diagnosis and treatment strategies for retroperitoneal vascular leiomyosarcoma

Advances in clinical management of thyroid cancer in children and adolescents

Related Author

江涛

苟欣

Zhang Xinyue

Shao Zijian

Lian Kang

Wu Demei

Yuan Bin

Wu Fang

Related Institution

重庆医科大学临床学院肺科

重庆医科大学临床学院泌尿科

Department of Traditional Chinese Medicine，Children’s Hospital，Zhejiang University School of Medicine/ National Clinical Research Center for Child Health

Department of Pediatrics，The Affiliated Hospital of Nanjing University of Chinese Medicine，The First Clinical Medical College of Nanjing University of Chinese Medicine

Department of Respiratory Medicine，Children’s Hospital，Zhejiang University School of Medicine/ National Clinical Research Center for Child Health

⁰